MDT - Medtronic plc


81.9
-1.020   -1.245%

Share volume: 8,193,676
Last Updated: 04-28-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.05%

PREVIOUS CLOSE
CHG
CHG%

$82.92
-1.02
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
45%
Profitability 41%
Dept financing 19%
Liquidity 25%
Performance 61%
Company vs Stock growth
vs
Performance
5 Days
-1.70%
1 Month
-4.48%
3 Months
-18.91%
6 Months
-10.72%
1 Year
-3.19%
2 Year
1.29%
Key data
Stock price
$81.90
P/E Ratio 
28.04
DAY RANGE
$81.25 - $84.00
EPS 
$3.59
52 WEEK RANGE
$79.93 - $106.33
52 WEEK CHANGE
-$3.37
MARKET CAP 
129.330 B
YIELD 
2.81%
SHARES OUTSTANDING 
1.284 B
DIVIDEND
$0.71
EX-DIVIDEND DATE
03-27-2026
NEXT EARNINGS DATE
08-19-2025
BETA 
0.32
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$8,459,983
AVERAGE 30 VOLUME 
$8,073,257
Company detail
CEO: Geoffrey S. Martha
Region: US
Website: medtronic.com
Employees: 95,000
IPO year: 1981
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies. It operates through four segments: Cardiovascular, Neuroscience, Medical Surgical Portfolio, and Diabetes Operating Unit. The Neuroscience Portfolio segment offers products for spinal surgeons, neurosurgeons, neurologists; neurologists, pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists.

Recent news